from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2213/pepB

LFCtreatmentdescriptionclass of inhibitor

0.384

Amikacinug/mL Amikacintranslation

0.651

Cap5-10ug/mL Capreomycintranslation

0.469

Rox10-50 ug/mL Roxithromycintranslation

0.992

SM2-5 ug/mL Streptomycintranslation

-0.282

Tet5-10 ug/mL Tetracyclinetranslation

0.215

Rif0.2-5ug/mL Rifampicintranscription

-0.020

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.659

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.459

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.396

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.654

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.038

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.541

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.872

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.492

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.057

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.470

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.089

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.435

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.725

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.871

KCN5-20 ug/mL Potassium cyaniderespiration

-0.390

NaN30.2-2 mM Sodium aziderespiration

0.875

Nigericin50 uM Nigericinrespiration

-0.832

TRC10-150 ug/mL Triclosanrespiration

-1.452

TRZ10-25 ug/mL Thioridazinerespiration

-1.923

Valinomycin0.5-10 uM Valinomycinrespiration

1.118

ZnSO42 mM ZnSO4respiration

1.005

menadione6-10 ug/mL Menadionerespiration

0.176

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.719

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.022

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.078

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.087

NRP_1Non-replicating persistence stage 1dosRassociated

0.375

Amp0.2mg/mL AmpicillincellWall

0.463

Cephalexin20-100 ug/mL CephalexincellWall

1.008

Cerulenin0.32-5 ug/mL CerulenincellWall

0.329

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.380

EMB10-20 ug/mL EthambutolcellWall

0.663

Eta12-40 ug/mL EthionamidecellWall

1.095

INH0.2-0.4 ug/mL IsoniazidcellWall

0.687

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.039

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.660

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.460

BZA0.12 mg/mL BenzamidearomaticAmides

-0.109

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.316

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.021

H2O24 mM hydrogen peroxideDNAdamaging

0.358

Levo10 ug/mL LevofloxacinDNAdamaging

0.787

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.197

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.795

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.577

UVUV-irradiationDNAdamaging

-0.190

ARP41-4 ug/mL Antitubercular compound ARP4?

0.443

Antimycin12.5-50 ug/mL Antimycin A?

0.596

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.339

PA_110-50 ug/mL Antitubercular compound PA-1?

0.261

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.593

PA8240.2-2 ug/mL PA-824?

-1.197

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.041

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.124

Verapamil50 uM Verapamil?

0.259

mercaptoethanol2 mM 2-Mercaptoethanol?

0.399

methoxatin10-20 ug/mL Methoxatin?